Isotretinoin-Induced Thrombocytosis

Arzu Ataseven, Gulcan Saylam Kurtipek, Fatma Tuncez Akyurek, Perihan Ozturk, Nursel Dilek


We report a case of thrombocytosis possibly associated with isotretinoin. The patient was a 19-year-old female who had severe acne vulgaris for 5 years. Systemic oral isotretinoin treatment was used daily at a dose of 0.5 mg/kg. All of the laboratory parameters were within normal limits, and the platelet count was 282,000/uL at the beginning of the treatment (reference range: 150,000 - 400,000/uL). In the following months, thrombocytosis (630,000/uL) was found, and the treatment was ended. The platelet count was in the normal range (343,000/uL) in the next monthly visit. The patient had no other illnesses or medications. The exact mechanism by which isotretinoin caused thrombocytosis in this patient is not clearly understood. To our knowledge, this case is the second case of isotretinoin-associated thrombocytosis. Clinicians who are prescribing isotretinoin should be aware of thrombocytosis, and a complete blood cell count with platelets should be part of the monthly monitoring routine in all patients receiving isotretinoin therapy.

J Hematol. 2014;3(2):61-62


Isotretinoin; Thrombocytosis; Drug

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics






Journal of Hematology, bimonthly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:    editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.